Vanousheh Ghandhari, DPM
Foot & Ankle Surgery · Chandler, AZNPI 1821409129
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Paragon 28, Inc. at 26.0% of the total. Reporting peaked in 2021 at $4,371 and has fallen 83.2% since, to $735 in 2025.
Across 153 payments — averaging $74.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$3K
- Arthrex$2K
- Stryker$2K
- Treace Medical Concepts, Inc.$2K
- Impactortho, Inc.$737
- DJO, LLC$672
- plus $2K from 31 others
What the payments were for
- Travel & lodging$4,23637%
- Food & beverage$5,40147%
- Education$1,79616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 14 | $2,974 |
| Arthrex | 11 | $1,717 |
| Stryker(2 entities) | 17 | $1,643 |
| Treace Medical Concepts, Inc. | 10 | $1,510 |
| Impactortho, Inc. | 4 | $737 |
| DJO, LLC | 7 | $672 |
| Amgen(2 entities) | 10 | $318 |
| AbbVie | 9 | $242 |
| Smith+Nephew | 6 | $234 |
| Fusion Orthopedics USA, LLC | 2 | $143 |
| Orthofix Medical, Inc. | 18 | $124 |
| Johnson & Johnson | 3 | $105 |
| Abbott | 2 | $91 |
| Globus Medical | 2 | $73 |
| Arteriocyte Medical Systems, Inc. | 2 | $64 |
| Forthright Medical - AZ, LLC | 2 | $64 |
| Integra Lifesciences Corporation | 3 | $62 |
| Surgenex LLC | 2 | $59 |
| Tactile Systems Technology Inc | 4 | $57 |
| Mimedx Group, Inc. | 2 | $56 |
| Angiodynamics, Inc. | 1 | $55 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Melinta Therapeutics, LLC | 3 | $41 |
| Nevro Corp. | 2 | $40 |
| Extremity Medical | 1 | $39 |
| Flower Orthopedics Coporation | 1 | $38 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $32 |
| Solventum Corporation | 1 | $25 |
| Biocomposites Inc | 1 | $25 |
| Zimmer Biomet | 1 | $25 |
| Convatec Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $17 |
| Anika Therapeutics, Inc. | 1 | $16 |
| Medela LLC | 1 | $12 |
| Rikco International, LLC | 1 | $11 |
| Aap Implants Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,247
- Product Portfolio$980
- TAR$659
- APEX$488
- DR COMFORT$424
- PROstep$386
- PROPHECY$352
- RAYOS$337
- INFINITY$143
- EVOS$136
- SMART TSF$136
- DISTAL EXTREMITIES IMPLANTS DYNANITE OTHER$124
- DISTAL EXTREMITIES IMPLANTS DYNANITE HAMMERTOE$124
- DISTAL EXTREMITIES IMPLANTS DYNANITE STAPLES$124
- VARIAX$123
How this compares
$11,433 in reported general payments places this provider in the 80th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 11 | $8,215 |
| Ciclopirox | 70 | $1,656 |
| Gabapentin | 82 | $791 |
| Methylprednisolone | 94 | $696 |
| Cephalexin | 87 | $678 |
| Nitro-BidNitroglycerin | 13 | $650 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $396 |
| Diclofenac Potassium | 13 | $334 |
| Doxycycline Hyclate | 20 | $218 |
| Colchicine | 11 | $186 |
| Terbinafine Hcl | 19 | $183 |
| Allopurinol | 18 | $136 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $101 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $34 | $8,21511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 291 foot & ankle surgery providers in Arizona.
Other foot & ankle surgery in Chandler
- Myron HansenChandler$480K
- Keith GossChandler$135K
- Urja ShahChandler$20K
- Raul AvilesChandler$11K
- Ryan ScottPhoenix$1.1M
- Jeffrey McAlisterScottsdale$578K
- Jeffrey HolmesPhoenix$509K
- Scott MalingMesa$382K
- Melissa GalliPhoenix$324K
- Geoffrey LandisTucson$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.